we might find that regulations are almost dead on arrival because as they are released another technology is emerging
Analysis
To ensure continued industry growth, particularly in medical devices and pharmaceuticals, a clear and simplified regulatory environment is essential.
Julio Sánchez y Tépoz
View from the Top
Julio Sánchez
Commissioner
COFEPRIS
COFEPRIS regularly removes patents from groups of medicines to allow for the production of generics.
The global contract research organization market is expected to reach a value of US$59 billion by 2020
Analysis
Mexico is trying to scale up its clinical research by taking advantage of its natural traits.
Cristina Viruega
View from the Top
Cristina Viruega
Director General
TAPVS
The sector is increasingly moving toward biotechnological medicines and TAPVS is becoming a key partner in the process.
Julio Sánchez
View from the Top
Julio Sánchez
Commissioner
Federal Commission for the Protection Against Sanitary Risks
We classified COFEPRIS’ shortcomings and assigned them to different teams based on their specific nature.
Subscribe to Julio Sánchez